Skip to main content
. 2017 Sep 30;34(10):743–754. doi: 10.1007/s40266-017-0491-5
Given new molecular identification techniques, a greater number of respiratory viruses are being identified.
The older transplant patient has a greater risk of lower respiratory disease from respiratory viruses.
Therapies are limited for the majority of viruses, and prevention is key.